Ondansetron for the prevention of seasickness in susceptible sailors: An evaluation at sea

Aviation Space and Environmental Medicine

Volumn 80, Issue 7, 2009, Pages 643-646

  Hershkovitz, Dov ^a,d   Asna, Noam ^b,d   Shupak, Avi ^c,d   Kaminski, Gil ^d   Bar, Ronen ^a,d   Tal, Dror ^d  

^a Rambam Health Care Campus ^*  (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c Carmel and Lin Medical Centers   (Israel)

^d ISRAEL NAVAL MEDICAL INSTITUTE   (Israel)

Author keywords

Motion sickness; Ondansetron; Pharmacological treatment

Indexed keywords

ONDANSETRON; PLACEBO;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; HUMAN; MOTION SICKNESS; NAUSEA; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SAILOR; SEA; TASK PERFORMANCE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; ADULT; COGNITION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; ISRAEL; MALE; MILITARY PERSONNEL; MOTION SICKNESS; NAUSEA; NAVAL MEDICINE; ONDANSETRON; PSYCHOMETRICS; QUESTIONNAIRES; SEROTONIN ANTAGONISTS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67651017722     PISSN: 00956562     EISSN: None     Source Type: Journal    
DOI: 10.3357/ASEM.2365.2009     Document Type: Article

References (18)

1. Barnes JM, Barnes NM, Costall B, Deakin JF, Ironside JW, et al. Identification and distribution of 5-HT3 recognition sites within the human brainstem. Neurosci Lett 1990; 111:80-86 (Pubitemid 20102122)
2. Benline TA, French J, Poole E. Anti-emetic drug effects on pilot performance: granisetron vs. ondansetron. Aviat Space Environ Med 1997; 68:998-1005. (Pubitemid 27483892)
3. Blackwell CP, Harding SM. The clinical pharmacology of ondansetron. Eur J Cancer Clin Oncol 1989; 25(Suppl. 1):S21-4 (discussion S25-7).
4. Borison HL, Borison R. Motion sickness reflex arc bypasses the area postrema in cats. Exp Neurol 1986; 92:723-737 (Pubitemid 16074649)
5. Figueredo E, Canosa L. Prophylactic ondansetron for post-operative emesis: meta-analysis of its effectiveness in patients with and without a previous history of motion sickness. Eur J Anaesthesiol 1999; 16:556-564 (Pubitemid 29435669)
6. Griffin MJ. Handbook of human vibration. London: Academic Press; 1990:271-332.
7. Kovac AL, Pearman MH, Khalil SN, Scuderi PE, Joslyn AF, et al. Ondansetron prevents postoperative emesis in male outpatients. S3A-379 Study Group. J Clin Anesth 1996; 8:644-651
8. 3) receptor antagonists on gastric tachyarrhythmia and the symptoms of motion sickness. Aviat Space Environ Med 2000; 71:1111-1114 (Pubitemid 30815833)
9. Lucot JB. Blockade of 5-hydroxytryptamine3 receptors prevents cisplatin-induced but not motion- or xylazine-induced emesis in the cat. Pharmacol Biochem Behav 1989; 32:207-210 (Pubitemid 19125940)
10. Money KE, Cheung BS. Another function of the inner ear: facilitation of the emetic response to poisons. Aviat Space Environ Med 1983; 54:208-211
11. Muth ER, Elkins AN. High dose ondansetron for reducing motion sickness in highly susceptible subjects. Aviat Space Environ Med 2007; 78:686-692 (Pubitemid 47047801)
12. Nachum Z, Shupak A, Gordon CR. Transdermal scopolamine for prevention of motion sickness: clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet 2006; 45543-45566 (Pubitemid 44046484)
13. Okada F, Torii Y, Saito H, Matsuki N. Antiemetic effects of serotonergic 5-HT1A-receptor agonists in Suncus murinus. Jpn J Pharmacol 1994; 64:109-114 (Pubitemid 24091838)
14. Stott JR, Barnes GR, Wright RJ, Ruddock CJ. The effect on motion sickness and oculomotor function of GR 38032F, a 5-HT3-receptor antagonist with anti-emetic properties. Br J Clin Pharmacol 1989; 27:147-157 (Pubitemid 19059476)
15. Treisman M. Motion sickness: an evolutionary hypothesis. Science 1977; 197:493-495
16. Wiker SF, Kennedy RS, McCauley ME, Pepper RL. Susceptibility to seasickness: influence of hull design and steaming direction. Aviat Space Environ Med 1979; 50:1046-1051 (Pubitemid 10240610)
17. Yates BJ, Grelot L, Kerman IA, Balaban CD, Jakus J, Miller AD. Organization of vestibular inputs to nucleus tractus solitarius and adjacent structures in cat brain stem. Am J Physiol 1994; 267(4, Pt 2):R974-83. (Pubitemid 2158879)
18. Yates BJ, Miller AD, Lucot JB. Physiological basis and pharmacology of motion sickness: an update. Brain Res Bull 1998; 47:395-406. (Pubitemid 29095346)